Historically our knowledge about the direct carcinogenic activity of cigarette smoke and its constituents grew from painting experiments on the skin of mice to produce papillomas and carcinomas. The neutral fraction of cigarette smoke condensate had most of the carcinogenic activity in this test and was rich in carcinogenic polycyclic aromatic hydrocarbons (PAHs), the most abundant by far being BP. However, the concentration of BP in the condensate was only about 2% the amount of pure BP required to cause skin tumors. In other fractions there were non-carcinogenic constituents that promoted tumor formation when applied repeatedly to mouse skin that had been initiated by a single subcarcinogenic application of BP. There were also constituents of cigarette smoke that acted as cocarcinogens when applied simultaneously with repeated applications of BP. BP was effective as an initiator at lower concentrations than as a complete carcinogen, and some non-carcinogenic PAHs in the condensate were also active initiators. It was concluded from these studies that cigarette smoke condensate is primarily a tumorpromoting and co-carcinogenic agent with weak activity as a complete carcinogen. A major effect of promoters, and possibly of co-carcinogens, is a diffuse hyperplasia which includes selective expansion of clones carrying endogenous mutations and/or mutations induced by PAHs and other carcinogens such as NNK. The induced mutations as well as damaged cells would occur throughout the exposed region and, along with the hyperplasia, increase the permissiveness of the cellular microenvironment for neoplastic expression of any potential tumor cell in its midst. Since neither the promoters nor co-carcinogens in tobacco smoke are known to interact directly with DNA, their effects can be considered epigenetic processes that act upon genetically altered cells. Examples are cited from studies of experimental skin carcinogenesis, smoking-induced histopathological changes in human lung and spontaneous transformation in cell culture to illustrate the genetic and epigenetic interactions of neoplastic development in general and their significance for smoking-induced lung cancer in particular. Certain dietary modifications that appear to be effective in moderating the promotional phase of animal and human carcinogenesis are suggested for trial in managing lung cancer.
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Introduction
Modern use of the term epigenetics refers to those processes through which the genotype, starting from the undifferentiated egg, gives rise to the differentiated phenotype (Waddington, 1942) . In this sense epigenetics emphasizes changes in gene activity during development (Holliday, 1987) . Since changes in gene expression occur during continuous differentiation of cells in adult life of multicellular organisms, the definition of epigenetics was generalized to cover the mitotic inheritance of given patterns of gene expression (Holliday, 1994) . When applied to tumor biology, epigenetics might generally be taken as those changes in either the phenotype or the microenvironment of genetically altered cells that allows their abnormal growth and neoplastic development. The interpretations of epigenetics lay stress on genetic modifications, but there are certain neoplasias such as teratomas and teratocarcinomas in which the mere change in the microenvironment of a normal tissue can result in a tumor or its reversion to normal development (Mintz and Illmensee, 1975 ). In such rare cases, ectopic placement of an embryo or a tissue selects for the neoplastic development of the cells, and restoration to the original microenvironment can lead to their reversion to a normal phenotype (Furth, 1953) .
Selection in tumor development can, however, be seen in a more familiar way in tumor development under the common rubric of promotion (Hennings et al., 1983; Parkinson, 1985) a term that first arose in studies of chemical carcinogenesis in rabbit skin using carcinogenic coal tar as an initiating agent and turpentine or wound healing as a promoter (Friedewald and Rous, 1944) . Application to mouse skin of PAHs as initiators and croton oil or TPA as promoters led to the concept that initiation is a mutagenic process and that promotion is epigenetic (Berenblum, 1974; Berenblum and Shubik, 1947b) , allowing expression of a neoplastic phenotype in the genetically altered cell (Reddy and Fialkow, 1983) . The driving force of promotion in skin is generally acknowledged to be selection of cells genetically altered by initiation so they multiply expansively rather than differentiate in response to the promoter (Parkinson, 1985; Yuspa et al., 1982; Yuspa and Morgan, 1981) . Further mutations occur during the clonal expansion and lead to progression of the neoplastic phenotype (Parkinson, 1985) .
Recently, disagreement has arisen about the extent that cigarette smoking induces lung cancer by direct induction of mutations by PAHs in the smoke (Denissenko et al., 1996; Hainaut and Pfeifer, 2001) or by non-genetic mechanisms such as selection by ingredients of the smoke (Rodin and Rodin, 2000) . The disagreement is based on conflicting interpretations of molecular mutations in specific codons of the p53 gene in lung cancers of smokers and non-smokers. The ensuing discussion made no reference to older biological observations on carcinogenesis induced by cigarette smoke and its constituents in experimental animals. The present article first surveys the development of our basic knowledge about tumor initiation, based largely on the painting of mouse skin with PAHs, and of the process of tumor promotion, mainly as driven by croton oil or its active ingredient, TPA. It then details quantitative studies on experimental carcinogenesis by cigarette smoke and its constituents including PAHs and a variety of substances that act as promoters and co-carcinogens. The primary conclusion of these studies is that the concentration of PAHs in cigarette smoke is far too low to account for tumor production by themselves, and that promotion and cocarcinogenesis by a variety of identified constituents play major roles in the process. This implies that nongenetic mechanisms such as selection that fall under the rubric of epigenetics warrant serious attention in understanding lung cancer in humans. Consideration has to be given not only to mutations that engender selectability of potential tumor cells, but alterations in the microenvironment that permit their clonal expansion into tumors (Rubin, 2001b,c) .
Cigarette smoking is the most important single cause of human cancer, its main manifestation being cancer of the lung. It is, of course, logical that the carcinogenic components of tobacco smoke be sought out by tests in experimental animals. The most relevant test would be the production of lung cancer by inhalation of cigarette smoke, but in the years after epidemiological studies had established cigarette smoking as the major cause of human lung cancer, attempts to produce lung tumors in mice by inhalation of the smoke either failed or could not be reproduced (Davies, 1960; Wynder et al., 1953) . Investigators therefore turned to the repeated application of cigarette smoke and its individual components to the skin of mice, the method developed for systematic studies of carcinogens in coal tar which was associated with occupational skin cancer in man. Repeated painting of mouse skin became the method of choice for demonstrating carcinogenic activity after the Kennaway group in England had used it to show that benzo(a)pyrene (BP) was the major carcinogen of coal tar (Cook et al., 1933) . The isolation of BP was preceded and followed by the chemical synthesis of other carcinogenic PAHs (Cook et al., 1937; Kennaway and Hieger, 1930) , some of which were later identified as minor components of coal tar.
The PAHs were generated at very high temperature during the processing of coal, and in fact are similarly generated in processing other organic products at high temperature. It therefore made sense to examine tobacco smoke for carcinogens by the same methods used for coal tar once inhalation proved unreliable, and to focus on the PAHs as the responsible constituents. After some initial failures by several investigators, Wynder and colleagues conducted a successful series of experiments on the capacity of cigarette smoke condensate and various fractions thereof to produce skin cancer in mice (Wynder et al., 1953; Wynder and Hoffmann, 1961) . A major conclusion was that BP and other carcinogenic PAHs occur in cigarette smoke condensate but their concentration is far too low to account, by themselves, for the carcinogenic activity of the condensate (Wynder and Hoffmann, 1959) .
In the meantime, there had been further progress in working out the details of skin carcinogenesis by PAHs. Perhaps the most significant of the findings was that a single application to the skin of a relatively low dose of BP or other carcinogenic PAHs would produce no tumor, but when followed by repeated applications of other substances that were by themselves non-or only weakly tumorigenic, many tumors were produced (Berenblum and Shubik, 1947a) . The subcarcinogenic single treatment with PAHs was called initiation, and the repeated treatment that brought on the tumors was called promotion. The single initiation treatment produced a long lasting change in mouse skin as shown by successful promotion begun 56 weeks later (Van Duuren et al., 1975) . Promotion, by contrast, was a gradual process that could be reversed by ceasing the repeated treatments any time before papillomas appeared, and in some cases, even when they were already present. While these experiments were first done with PAH as initiator and croton oil or TPA as promoter, they were later extended to tobacco smoke and its ingredients. It became apparent that both initiation and promotion, and perhaps other processes, were necessary for tumor production by tobacco smoke. What follows is a detailed analysis of skin carcinogenesis in experimental animals by PAHs, promoters and co-carcinogens, and their potential relevance to lung carcinogenesis in humans by cigarette smoking. The results will be applied to help resolve the dichotomy between the direct induction of mutations by PAHs in cigarette smoke and its selection of preexisting mutations. mouse skin resided in the neutral fraction which contained most of the PAHs of the tar from burning cigarettes (Wynder and Wright, 1957) . The major tumor-producing activity of the neutral fraction in a subfraction eluted from chromatograms with carbon tetrachloride which contained eight identified PAHs, including BP as well as some unidentified PAHs (Wynder et al., 1957b) . Further studies of the PAHs with 4, 5 and 6 condensed nuclei in cigarette smoke condensate indicated they were the major but not the only skin carcinogens in the condensate (Wynder and Hoffmann, 1959) . It is therefore appropriate in understanding tobacco carcinogenesis to review the main features of skin carcinogenesis by the PAHs.
Among the most significant of these features is the requirement for repeated painting of the skin of mice or rabbits over a period of several months before papillomas appear, with further applications to produce carcinomas. For example, painting of mouse skin with 0.03% of either DB(a,h)A or BP twice a week for 8 weeks yielded no tumors, but painting for 8 weeks with DB(a,h)A followed by 8 weeks of BP was highly tumorigenic (Hieger, 1936) . Sarcomas could be produced in mice by a single subcutaneous injection of BP but only if it was dissolved in vehicles which allowed its persistence for more than 5 or 6 months (Peacock and Beck, 1938) . Rabbits which were very susceptible to skin carcinogenesis by topical application of DMBA were highly resistant to subcutaneous injection (Berenblum and Shubik, 1949) . The resistance of rabbits to subcutaneous injection was correlated with the much faster disappearance of DMBA from the subcutaneous tissue of rabbits than of mice. Related aspects of the persistence of PAHs in carcinogenesis were recently reviewed (Rubin, 2001c) . The obvious significance of these findings for lung carcinogenesis in humans is its correlation with long term cigarette smoking, and the long interval between the increase of smoking in populations and subsequent rise in death rates from lung cancer (Cairns, 1978) .
Although several months of repeated application of carcinogenic PAHs are required to produce a full crop of papillomas, a mild hyperplasia is seen within 6 days of a single low dose application (Cramer and Stowell, 1942b; Setala et al., 1959; and Figure 1A ,C) that partly subsides by 30 days ( Figure 1D ). At high PAH concentrations, there is widespread death of keratinocytes in the central area of direct application in the first few days with cell proliferation in the peripheral area (not shown). With multiple applications of lower doses, there is an extremely high degree of hyperplasia at 30 days, with irregularity of size and shape of cells and nuclei and an abnormal distribution of chromatin (Rubin, 2001c; Setala et al., 1959; and Figure 1E ). The persistent hyperplasia is a critical feature of the cellular response to the PAHs in their role as complete carcinogens that need no accessory treatments to produce tumors. Complete carcinogens are distinguished from incomplete carcinogens like urethane which produce no hyperplasia but will generate tumors if followed by repeated treatment with agents that produce hyperplasia but are not in themselves carcinogenic (Salaman and Roe, 1953) .
After 12 weeks of painting with MCA three times a week, a diverse reaction can sometimes be seen in a single broad low power field consisting of hyperplastic epidermis, regenerating hair follicles, benign and precancerous papillomas and invasive carcinoma (Cramer and Stowell, 1942b; Rubin, 2001c; and Figure  1H ). These morphological changes in treated skin are specific for carcinogenic as opposed to non-carcinogenic PAHs (Cramer and Stowell, 1942b; Pullinger, 1940; Setala et al., 1959) . The smaller the dose of a particular carcinogenic PAH required to provoke the aberrant hyperplasia the shorter is the latent period for tumor production by that PAH relative to other PAHs (Pullinger, 1941) . This indicates a close relationship between the extent and type of initial hyperplasia and the much later appearance of tumors. Since the hyperplasia included the entire population of treated epidermal cells and was strongly correlated with tumor production, it suggests an important role for nongenetic processes, such as promotion in production of tumors.
Chromosomal responses to PAH treatment
The first indication of possible chromosomal involvement in PAH carcinogenesis came from the observation of abnormal chromatin distribution in histological sections (Cramer and Stowell, 1942b) . There were no adequate methods at the time for identifying individual chromosomes, but the general mass of chromosomes could be characterized in squashes of epidermal cells (Biesele, 1943) . Squashes were made at various times after starting multiple applications of MCA. An approximate doubling in the size of stained chromosomes began at 3 days in about 8% of the squashed epidermal cells. That appeared to reflect an increase in chromosomal strands rather than a mere swelling. The proportion of cells with this alteration was relatively constant for 2 months, rose to 20 -30% at 72 days but decreased to 0 -2% in the papillomas that appeared later. The decrease indicated there was selection against chromosome abnormalities in development of the tumors. Carcinoma development was marked by an increase to 40 -76% in cells with chromosome abnormalities.
The problem was reinvestigated a quarter century later using techniques that allowed discrimination of individual chromosomes as well as their breaking and rejoining. The first experimental object was Chinese hamster cells in culture with their easily identified set of 22 metacentric chromosomes (Kato, 1968) . Single chromatid and chromosome breaks were seen in 23% of the cells 12 h after starting a 24 h treatment with DMBA, and rising to 55% at the end of the treatment (Table 1 ). The proportion of breaks increased to 90% at 24 h after removal of DMBA, and decreased gradually in the next 72 h. There was no significant rejoining of chromosomes during presence of DMBA but it then rose to 77% by 24 h after removal of DMBA and, like chromosome breaks, gradually declined in the next 72 h. By the fifth serial subculture of the cells, most of them were diploid, but the frequency of cells with structurally new chromosomes arising from rejoining between different chromosomes was about fourfold higher than in normal cells.
Chromosome breaks also occurred in bone marrow cells of Chinese hamsters after subcutaneous or intraperitoneal injection of DMBA (Kato et al., 1969) . The percentage of breaks in the treated hamsters tended to be much lower than those in the cultured cells, suggesting greater chromosomal stability in the normal environment of the body. This surmise was buttressed by the much larger proportion of chromosome breaks in the untreated controls of the cultured cells (8%) than in the control hamsters (0.4%). Multiple chromosome breaks were common in DMBA-treated cells in culture and in the hamster but these were apparently selected against in the long term. Interchromosomal exchanges provide opportunities for gene rearrangements that could affect gene regulation and increase the likelihood of neoplastic development.
Initiation and promotion of carcinogenesis
The first clearcut indications that there was more than a single stage in PAH carcinogenesis came from experiments in rabbit skin by Peyton Rous and his associates at the Rockefeller Institute. They painted rabbit ears repeatedly for months with coal tar to produce papillomas then stopped the painting and found that most of the papillomas disappeared over an 8 month period (Rous and Kidd, 1941) . Resumption of the coal tar painting resulted in reappearance of some of the papillomas at the site of regressed tumors in less than 1 month, indicating that some of the cells had not been lost but reverted to a non-tumorous state. These could be quickly restored to neoplastic behavior by reapplication of the coal tar. It was then found that substituting turpentine, a non-tumorigenic irritant, for coal tar in the second stage restored some of the regressed tumors and produced some new ones in the treated area. A similar second stage of papilloma appearance was produced by punching a large hole (discing) in the area pretreated with coal tar, and creating a prolonged period of wound healing from the edge of the hole inwards, with active proliferation of epidermal cells (MacKenzie and Rous, 1941) . No tumors were produced by punching a hole in the opposite ear which had not been pretreated with coal tar.
A comparison was made of tumor production by coal tar and by two purified PAHs, BP and MCA (Friedewald and Rous, 1944) . Tumors appeared much earlier when the ear was treated with coal tar than with large amounts of BP, which was considered the main carcinogen of the tar. This was an unexpected result because the amount of BP in the tar was much lower than that applied in the pure state. The tar-induced tumors also enlarged much faster than the BP-induced tumors and were more likely to develop carcinomatous characteristics. MCA was a more potent tumor producer than BP, but less potent than tar. The strong neoplastic effect of the coal tar was attributed to the hyperemic and inflammatory effects produced in the underlying dermis thought to enhance the proliferation of cells altered by the PAHs in the tar. Punching a hole in the ear that had been treated for months with BP brought out tumors that were not previously seen. The great enhancement of tumor development by coal tar despite the minute amounts of known carcinogens indicated that the carcinogenic potency of complex mixtures could not be predicted on the basis of the carcinogens known to be present. The term initiation was introduced to describe the initial alteration induced by the carcinogen, which did not necessarily result in appearance of a tumor, or produced a reversible tumor. Promotion referred to the persistent proliferation of the initiated cells necessary to produce a tumor. It was thought that the coal tar was particularly rich in promoting substances.
Experiments related to those in rabbits were in progress in mice about the same time. They began with an examination of the effects on tumor formation of applying 0.05% BP and 0.5% croton oil or croton resin repeatedly either together or separately in a procedure called co-carcinogenesis (to be considered later in tobacco carcinogenesis) (Berenblum, 1941a) . The co-carcinogenic treatments caused a rise in tumor incidence from 0 -6% with the dilute BP alone to 37 -80% with BP plus croton oil or its crude fractionation Epigenetics of tobacco carcinogenesis H Rubin product, croton resin. The tumor incidence with croton oil alone was 2% and with croton resin alone 0%. The procedure was modified by separating temporally the application of BP and croton oil to determine whether the co-carcinogenic of croton oil operated throughout the latent period or only during the early or late phase of the overall process. In one group of mice croton oil was applied before the start of the BP treatment, and in the other group after completion of a limited period of BP treatment (Berenblum, 1941b) . Pretreatment with croton oil had no apparent effect while post-treatment dramatically increased tumor incidence. Since croton oil effectively completed the carcinogenic process begun by an inadequate dose of BP but could not effectively start the process Berenblum concluded that the start and completion of the carcinogenic process involved different mechanisms. He also found in a separate group that applying croton oil after papillomas had appeared as a result of repeated BP application resulted in a significant increase in progression to carcinomas.
A useful refinement of the two-stage technique was to apply the carcinogen to mouse skin in a single initiating dose which did not by itself produce tumors, followed by repeated applications of croton oil for promotion (Mottram, 1944) . This facilitated analysis of the two-stage phenomenon in quantitative terms while reducing the possibility of the initiator contributing to the subsequent promoting action. Because of its utility, the simplified two-stage method of one-step initiation followed by repeated promotion became a standard operation. It almost completely displaced the cocarcinogenesis procedure of repeated parallel application of carcinogen and co-carcinogen, except in tobacco carcinogenesis where that procedure yielded significant results to be discussed below.
The initiation step by PAHs was induced quickly and irreversibly, thereby exhibiting the characteristics of a mutation (Berenblum and Shubik, 1947a) . Promotion required repeated application and could be reversed if halted before tumors appeared. It seemed therefore to provide conditions such as hyperplasia for the neoplastic expression of initiated cells. The application of croton oil could be delayed for 20 weeks after PAH treatment without loss of tumor production. In all the intervening time the initiated cell could not be readily distinguished from non-tumor cells except by the ex post facto method of promotion. The initiation-promotion procedure established that incipient tumors could remain without neoplastic expression for much of the life of the mouse, with presumed parallels in humans.
Fractionation of croton oil revealed that the active promoting agent is TPA (Hecker, 1968) . Other promoting substances, such as the membrane active agents sodium lauryl sulfate and Tween 60 which were classified as weak promoters by some , whereas others found they produced a wide range of promotion (Setala et al., 1959) . However, TPA has the strongest promoting action of any substance reported to date.
Croton oil and presumably TPA induce a marked hyperplasia of epidermal epithelia which is maintained throughout the entire period of repeated applications (Shubik, 1950) . Although hyperplasia is apparently a prerequisite for promotion, not all agents that induce hyperplasia are promoters (Berenblum, 1974) . It is noteworthy that carcinogenic PAHs produce lasting hyperplasia when repeatedly applied and thereby act as their own promoters. TPA also produces cell damage, edema and acute inflammation in both epidermis and dermis (Aldaz et al., 1985) . The more moderate promoter Tween 60 produces intense cell proliferation and hyperplasia but not the cell damage produced by TPA, nor the cellular and nuclear atypias and disturbances in cell -cell organization characteristic of repeated application of the carcinogenic PAHs (Cramer and Stowell, 1942a; Setala et al., 1959) .
As already noted, croton oil or TPA treatment alone can result in some tumor production and it has been debated whether it should be considered a weak carcinogen rather than just a promoter (Berenblum, 1974) . The extent of tumor production by TPA depends on the strain of mouse being treated. Repetitive painting of the Oslo strain of hairless mice with 17 nmol TPA produced tumors in 28% of the mice in 39 weeks (Iversen, 1985) . Since TPA is nonmutagenic in hamster cells (Lankas et al., 1977) and does not require metabolic activation for its promoting effect (Berry et al., 1978) , it is widely believed that it is selecting endogenous mutations. Support for this point of view comes from the similarity of simple base pair substitutions in 279 different genes of most human cancers (excluding a small subset of p53 mutations) and germline mutations (Krawczak et al., 1995) . If, as seems to be the case, there are many mutations in somatic cells (Dolle´et al., 2000) , it would be difficult to distinguish between a strong promoter and a weak carcinogen. However, weaker promoters like Tween 60 rarely if ever produce tumors by themselves. TPA greatly increases the efficiency of tumor production by PAHs, since it requires at least 10 times more PAH acting alone as a complete carcinogen to produce as many tumors as the amount of PAH needed in the initiation-promotion sequence with TPA (Marx, 1978) . This will be an important consideration in considering how the relatively small amounts of PAHs in tobacco smoke might participate in tumor production.
Two stages of promotion
Promotion, like initiation, was for years thought to be a single process, but it involved selection through a strong and persistent hyperplasia of cells initiated by mutation. In 1964, however, several experiments indicated that promotion consisted of two stages (Boutwell, 1964) . In one of the experiments, application of croton oil to initiated mouse skin for 6 weeks produced few tumors but extension of the treatment to 14 weeks produced many. Substitution of turpentine for croton oil in the last 8 weeks also produced many tumors but exclusive use of turpentine for the full 14 weeks produced none. The results indicated that croton oil could carry out all the full program of promotion but turpentine could only carry out the second phase. The first phase of promotion was called conversion to signify the change of an initiated cell to a dormant tumor cell. The second phase was called propagation because of its dependence on cell proliferation. When TPA was recognized as the active promoting ingredient of croton oil, it was substituted in the two stage experiments, and purer substitutes were sought for turpentine. Mezerein is a diterpene similar to TPA which elicits most of the biochemical changes and hyperplasia of TPA but is less than 1/50th as active as a promoter (Slaga et al., 1980) . Treatment of DMBAinitiated mouse skin with TPA for 20 weeks yielded many papillomas but TPA treatment for only 2 weeks yielded none at 20 weeks. Treatment of the initiated skin with mezerein for 20 weeks yielded only a few tumors, but if the mezerein treatment followed 2 weeks of TPA treatment there were many tumors. Mezerein therefore appeared to be acting mainly as a propagator or second stage promoter after conversion of the initiated skin by TPA.
Another second stage promoter was RPA, which substituted a retinoic acid residue for the long fatty acid chain of TPA (Fu¨rstenberger et al., 1981) . It evokes epidermal hyperplasia as effectively as TPA but is a very poor promoter by itself. It was used as a propagator after conversion by TPA in a variety of experiments to characterize more fully these two stages of promotion. RPA application was begun at successively longer intervals after TPA treatment of initiated skin (Fu¨rstenberger et al., 1983) . RPA retained promotional activity, albeit somewhat reduced, if started 8 weeks after TPA treatment ceased, indicating relative stability of the convertogenic phase induced by TPA. This raised the question of whether the convertogenic phase could be induced by TPA application before treatment with the PAH (Fu¨rsten-berger et al., 1985) . TPA treatment 2 -6 weeks before initiation with DMBA followed by repeated application of RPA produced almost as many papillomas as the conventional prolonged application of TPA after initiation.
The relative stability of the convertogenic stage and the absence of direct interaction between TPA and DNA raised the possibility that it was indirectly producing chromosome aberrations. In fact, numerical and structural chromosome aberrations were induced by TPA treatment of mouse keratinocytes (Dzarlieva- Petrusevska and Fusenig, 1985) . The aberrations included gaps, chromatid breaks and chromosomal exchanges that were visible within 24 h of treatment with TPA. Brief treatment of the mouse keratinocytes also produced double minute chromosomes which are a sign of gene amplification (Petrusevska et al., 1988) . Treatments that inhibit promotion by TPA in initiated skin also inhibited chromosome aberrations, consistent with a causal relationship between those aberrations and the process of conversion.
Although almost all of the systemic work on tumor promotion has been done on mouse skin, there is evidence that it is also effective in other organs. Newborn AKR mice receiving a single subcutaneous injection of dimethylnitrosamine develop no adenomas in the lung (Armuth and Berenblum, 1972) . When such treatment is followed by repeated intraperitoneal injection of TPA, which by itself produces no tumors, a high percentage of the mice develop adenomas in the lung ( Table 2) . The results thus demonstrate a pronounced promoting action of TPA in the lungs of newborn mice. This is a significant point in later consideration of the role of promotion and, by inference, selection, in pulmonary carcinogenesis by cigarette smoking.
Metabolism of PAHs and binding to DNA
An early idea about the mechanism of carcinogenesis by PAHs was based on their structural relation to steroids (Phillips, 1983) . Careful examination indicated a strong steric resemblance between the carcinogenic PAHs with four or five condensed aromatic nuclei and the steroids (Yang et al., 1961) . There appeared to be an increase in carcinogenicity of the PAHs as they became sterically more similar to steroids. Interest in this relationship dropped with the finding that a small fraction of several radioactively labeled PAHs applied to mouse skin bound firmly to cellular DNA, RNA and protein (Brookes and Lawley, 1964) . Only the binding to DNA showed a correlation with the carcinogenicity of the PAHs. The time course of the binding to DNA suggested that metabolism of the PAHs had to precede the binding.
The identification of the PAH metabolites that bound covalently to DNA was revealed 10 years later when radioactively labeled BP was incubated with primary cultures of Syrian hamster cells (Sims et al., 1974) . The results indicated that BP is metabolized in cells to the 7,8-dihydrodiol which is a precursor to the 7,8-dihydrodiol-9,10-epoxide (BPDE) that reacts with cellular DNA. The BPDE bound mainly to guanine residues of DNA (Weinstein et al., 1976) . The diol epoxides of DMBA and DB(a,l)P bind extensively to adenine residues of DNA (Cheng et al., 1988; Ralston Early testing of the PAHs as mutagens in various systems failed to yield consistent positive results (Burdette, 1955) . Subsequent results indicated that the PAHs had to be metabolized by target tissue in order to induce tumors, and that the metabolites could be generated by TPNH-dependent microsomal systems of liver. Mixing the PAHs with liver homogenates yielded products that were potent frameshift mutagens in certain mutants of Salmonella typhimurium bacteria (Ames et al., 1973) . Since bacteria do not metabolize the PAHs to their active intermediates, they can be used to test individual metabolites for mutagenic activity. Similarly, the V79 line of Chinese hamster cells lack the capacity to metabolically activate PAHs, so it can also be used to test individual metabolites for mutagenic activity (Huberman and Sachs, 1974 ). An extensive comparison of mutagenic and carcinogenic activities was carried out by Conney and associates in the late 1970's and was reported in a series of papers (Levin et al., 1977a (Levin et al., ,b, 1978 . BP and BP-7,8-dihydrodiol were equally strong complete carcinogens on mouse skin but were non-mutagenic in either V79 hamster cells or S. typhimurium. BPDE-2 was a weak carcinogen in mouse skin but was highly mutagenic in both test systems. BPDE-1 produced no tumors in mouse skin but like its isomer BPDE-2 was highly mutagenic in both test systems. The poor capacity of the diol epoxides to induce skin tumors despite their high mutagenic activity and binding to DNA in hamster cells was attributed to their instability. Since they were the direct metabolic products of the strongly carcinogenic BP-7,8-diol however, and they exhibited mutagenic and DNA-binding capacity, the diol epoxides were considered to be the ultimate carcinogens of BP. This designation was extended to the bay region vicinal epoxides of the other carcinogenic PAHs.
BPDE-2 proved to be a stronger initiator of skin carcinogenesis than a complete carcinogen. Of the four enantiomers of BPDE, the (+)-BPDE-2 was about 60% as active a tumor initiator as BP (Slaga et al., 1979) . The other three enantiomers had little or no tumor initiating activity. The relatively high initiating activity of the (+)-BPDE-2 compared to its weak activity as a complete carcinogen suggests that it was deficient in promoting activity.
Although a weak complete carcinogen on mouse skin, BPDE-2 proved an extremely potent inducer of lung adenomas when inoculated intraperitoneally into newborn mice (Buening et al., 1978; Kapitulnik et al., 1978) . It was 40 -50 times more active than its parental hydrocarbon, which supported its designation as the ultimate carcinogen of BP but leaves unresolved the question of its weak carcinogenicity on mouse skin. The latter question is underscored by the observation that the application of pure BPDE-2 to mouse skin results in its binding to DNA of the epidermal cells to the same extent as it does as a metabolite following the application of BP (Pelling and Slaga, 1982; Pelling et al., 1984) . This argues against its instability and reactivity as the explanation for the weak carcinogenicity of BPDE-2 in mouse skin. There is the additional problem that BPDE-1 binds almost as well as BPDE-2 to DNA, and is highly mutagenic in bacteria and V79 hamster cells, but causes no tumors either in mouse skin or newborn mouse lungs. These disparities between BPDE-1 and BPDE-2 in the relationship of binding to DNA on the one hand and carcinogenesis on the other remain to be explained in a satisfactory manner. It should be noted however, that extensive testing showed BPDE-2 to be a much more efficient mutagen than BPDE-1 (Newbold et al., 1979) .
The low carcinogenic activity in skin of the BP-diol epoxides, despite their high binding to DNA and mutagenic activity, can be explained by the recent finding of an alternative pathway of metabolism for their highly carcinogenic immediate precursor, BP-7,8-dihydrodiol. The precursor is converted by dihydrodiol dehydrogenase to the corresponding catechol of BP and successively to the o-semiquinone anion radical and the o-quinone (Burczynski and Penning, 2000) . These products enter futile redox cycles which amplify reactive oxygen species many times. The increased concentrations of active oxygen, organic peroxides and radicals are known to promote initiated cells to neoplastic growth (Cerutti, 1985) in addition to mutating DNA. The absence of reactive oxygen species when BP-diol epoxides are applied to skin and the consequent lack of promotion would account for their low carcinogenic activity there, in contrast to the high carcinogenic activity of their immediate precursor.
PAHs in cigarette smoke
Once epidemiological investigations established a strong association between cigarette smoking and lung cancer in man Hill, 1950, 1952; Wynder and Graham, 1950) , serious efforts began to produce cancer in animals by inhalation of cigarette smoke. Early positive results producing lung tumors in strain A mice (Essenberg, 1952) were dismissed as unimportant partly because the tumors were adenomas rather than bronchiogenic carcinomas (Wynder et al., 1953) , then the major form of lung cancer in humans. The early results were not reproducible, and it was not until 1974 that lung tumors were again produced, this time adenocarcinomas in Snell's strain of mice (Leuchtenberger and Leuchtenberger, 1974) . Not much attention was paid to these results, possibly because the Snell's strain developed spontaneous lung tumors and both the spontaneous and induced tumors were adenomatous. Since then however, adenocarcinoma has become the most common type of lung cancer in the United States (Thun et al., 1997) .
With the early difficulties in producing lung cancer in mice, efforts to establish the carcinogenic activity of cigarette smoke turned to applying smoke condensate repeatedly to mouse skin, the method developed to assay the carcinogenic activity of coal tar and PAHs. The CAF 1 mice used to produce skin tumors in a systematic series of studies by Wynder and his associates were genetically homogeneous F1 hybrids from a cross of A/Cloudman inbred strain of males with Balb/c in bred strain females (Wynder et al., 1953) . Painting skin three times a week with condensate produced papillomas in 50% of the mice in an average of 56 weeks and carcinomas in 44% of the mice in 71 weeks. Condensate had to be obtained from tobacco heated at least to 7208C to produce papillomas and at 8008C or higher to produce both papillomas and carcinomas, the latter temperature being close to that of burning cigarettes (Wynder et al., 1958) .
In order to determine the carcinogenic constituents of cigarette smoke condensate, it was fractionated by chemical means, molecular distillation and ionexchange chromatography (Wynder and Wright, 1957) . The neutral fraction which contained most of the PAHs, including BP of the condensate, had the strongest carcinogenic activity on mouse skin. The BP content of the total condensate and of its active fractions was far too low to account for their tumorproducing capacities (Wynder et al., 1957b) . This was also true for the other known carcinogens. Most of the tumor-producing capacity of the neutral fraction eluted from chromatograms with carbon tetrachloride (Wynder and Wright, 1957) . This subfraction contained some eight identified PAHs, including BP, and some that were unidentified. The amount of BP in the subfraction was less than 4% the amount of pure BP required to account for the tumor-producing activity of the subfraction, indicating that the other substances were contributing to tumor formation. This conclusion was reinforced in studies of PAHs with four, five and six condensed nuclei in the condensate in which BP could account for 1.6 -2.4% of the tumorigenic activity present (Wynder and Hoffmann, 1959) . Subcutaneous inoculation of condensate indicated that less than 0.5% of the sarcoma-producing activity could result from the amount of BP in the condensate (Druckrey and Schildbach, 1963) . It was concluded that more than 99% of the tumor-producing activity consisted of co-carcinogens.
Tumor promoters in cigarette smoke
Several other attempts to demonstrate initiation in cigarette smoke condensate failed but did find suggestions of promotion (Roe et al., 1959) . A large scale series of experiments was undertaken to examine the promoting activity in cigarette smoke condensate by painting mouse skin that had been given a threshold dose of BP (Gellhorn, 1958) . The condensate was obtained by combustion of cigarette tobacco at the relatively low temperatures of 5008 -7008F and induced only a few tumors when painted repeatedly in gradually increasing doses on the skin of large numbers of mice (Table 3) . Two paintings of BP produced few tumors, but there was a significant increase in papillomas and a large increase in carcinomas when BP was followed by frequent paintings of condensate. It was concluded that the condensate was acting as a 'co-carcinogen', although the procedure would now qualify it as a promoter. The combination of condensate and croton oil produced no more tumors than the sum of tumors produced by each alone (not shown), indicating that the condensate had minimal tumor-initiating activity. Confirmation of the promoting activity of the condensate using DMBA as initiator was obtained later, leading the authors to assert the 'condensate showed remarkable promoting activity' (Van Duuren et al., 1971 , 1966 and Table 3 ).
The phenolic fraction of tobacco smoke condensate was examined for promotional activity in a strain of mice inbred for susceptibility to tumor production by carcinogens and promoters (Roe et al., 1959) . DMBA in a single application was used as initiator, and the phenolic fraction was applied 36/week throughout the experiment. The phenol fraction itself produced no tumors, and DMBA alone produced papillomas in only one-tenth of the mice (Table 4) . Combination of the two produced papillomas in three-quarters of the mice, with an average of more than four per mouse, and one or two carcinomas for the entire group.
BP is the major identified PAH carcinogen in cigarette smoke, and its concentration was considered too low for complete carcinogenesis (Roe et al., 1959) in these models. However, it was thought that it could act as initiator, especially when combined with other PAHs in the condensate such as BA and DB(a,c)A that are negative or borderline as carcinogens but are relatively potent initiators (Van Duuren et al., 1970) . There may also be present in condensate other types of compound such as urethane that can produce skin tumors only with the aid of promoters (Roe and Salaman, 1955; Salaman and Roe, 1953) . The weak carcinogenic effect of the smoke condensate was attributed to the low concentration of initiators, based on the increase in its carcinogenicity upon addition of known initiators (Roe et al., 1959) . By contrast, the failure of added promoters to increase tumor production by smoke condensate was interpreted to mean that there were already saturating amounts of promoters in the condensate. It was considered likely that the lung cancers associated with smoking were driven predominantly by the tumor-promoting effect of the smoke on the bronchial epithelium (Roe et al., 1959) . The projection was compatible with reports that the phenol fraction promotes tumor formation in initiated skin at (Wynder, 1961; Wynder and Hoffmann, 1969) . There is also some promotional activity in the acid and neutral fractions of the condensate.
Co-carcinogens in cigarette smoke
Although there is a large body of information on promoters and their mechanism of action, the promotional procedure of a single application of a PAH carcinogen followed by multiple applications of promoters does not simulate the simultaneous, long term exposure of smokers to the many components of cigarette smoke. However, the much less studied procedures of co-carcinogenesis in which carcinogen and accessory substances are applied simultaneously over extended periods of time is a closer fit to the extended exposure of human smoking. Accordingly, 21 compounds were tested for co-carcinogenic activity, 18 of which are found in cigarette smoke condensate (Van Duuren and Goldschmidt, 1976; Van Duuren et al., 1973) . Seven of the compounds were strong cocarcinogens that occur in cigarette smoke condensate (Van Duuren and Goldschmidt, 1976) . The more effective of these increased the incidence of papillomas and carcinomas 3 -5-fold over that produced by BP alone (Table 5 ). They were found among all four of the chemical classes tested: phenols (catechol); nonaromatic hydrocarbons (decane, undecane, tetradecane); non-carcinogenic aromatic hydrocarbons (B(e)P, benzo(g,h,i)perylene); and long chain alcohols and acids (lauryl alcohol, stearic acid). Catechol is the most abundant phenol in the condensate. The 2 mg dose of catechol per application used as a cocarcinogen is equal to the amount in 4 -5 non-filter cigarettes and in 8 -10 filter cigarettes. It was later confirmed as a major co-carcinogen in the weakly acidic fraction of cigarette smoke (Hecht et al., 1981) .
Although it was at first thought catechol might enhance the activity of enzymes that convert BP to a proximal carcinogen (Van Duuren et al., 1973) , it was later found to actually inhibit the activity of the aryl hydroxylating enzymes (Van Duuren and Goldschmidt, 1976) . The wide disparity of compounds that are cocarcinogens makes it highly unlikely that they have a common chemical mechanism. Catechol causes dermatitis in humans, so it may cause hyperplasia in mouse skin although it is not effective as a promoter. It may have to act closely in conjunction with the PAH carcinogens if it lacks the capacity to induce chromosome aberrations, which are characteristic of the first or convertogenic stage of promotion (Kaina, 1989) . Stearic acid is a normal glyceride in animal fats and oils and in some vegetable oils. It might be relevant to recall that long-persisting subcutaneous deposits of injected cholesterol eventually produce sarcomas in rats, particularly in certain susceptible strains (Hieger, 1962) , and so do a variety of chemically unreactive Five mg BP was applied in the same solution as the co-carcinogen in 0.1 ml acetone three times weekly to the dorsal skin of 50 female Swiss mice for 368 or 440 days. Controls of BP or co-carcinogen alone in acetone, or acetone alone, were similarly applied Epigenetics of tobacco carcinogenesis H Rubin solids when inserted as sheets in the subcutaneous tissue of rodents (Brand et al., 1976) . Hence, abnormal distribution of normal substances, such as stearic acid, may enhance the carcinogenic potency of PAHs in multiple simultaneous injections. Co-carcinogenesis may in fact be acting as a selective process in some ways analogous to promotion. It should be noted, however, that some compounds such as TPA are effective as both promoters and co-carcinogens, others such as catechol are only effective in the co-carcinogenic procedure. Be that as it may, most of the identified co-carcinogens in cigarette smoke other than the non-carcinogenic PAHs are unlikely to interact directly with DNA. It would therefore be proper to characterize their action as epigenetic. Unfortunately, nothing is known about the role of epigenetic processes that might be induced by the tobacco-specific Nnitrosamines such as NNK and NNN, which are thought to be other major lung carcinogens in cigarette smoke in addition to the PAHs (Hecht, 1999) .
Mutation and/or selection in tobacco carcinogenesis
The quantitative biological studies just described were in agreement that the concentration of carcinogenic PAHs in tobacco smoke condensate was far too low to initiate skin or subcutaneous tumors by themselves (Druckrey and Schildbach, 1963; Roe et al., 1959; Wynder et al., 1957a,b; Wynder and Hoffmann, 1959; Wynder and Wright, 1957) . In contrast, the content of promoters and co-carcinogens was sufficient to produce tumors in mouse skin that had either been initiated by a single dose of PAH (Gellhorn, 1958; Roe et al., 1959; Van Duuren et al., 1966) or by repeated simultaneous applications of weak doses of PAH with various constituents of the condensate (Van Duuren and Goldschmidt, 1976; Van Duuren et al., 1973) . It was also noted that some PAHs that were themselves borderline or non-carcinogens could act as initiators when followed by promoters (Van Duuren et al., 1970) . The repeated application of TPA to uninitiated mouse skin produced a small fraction of the number of tumors that were produced by its application to PAHinitiated skin. This shows that there were not enough endogenous mutations in skin to be selected by TPA for maximum carcinogenic effect. This in turn would indicate that cigarette smoke is active as both a mutagenic and a selective agent. Although these studies were done in skin, it has been shown that TPA is an effective promoter of lung adenomas in mice initiated with a single subcutaneous dose of the mutagen dimethylnitrosamine (Armuth and Berenblum, 1972) . Given the demonstrated role of selection in the propagative stage of promotion by TPA in mouse skin, it is evident that selection could play a significant role in lung cancer as well. A widely noted report showed that there was strong and selective adduct formation in BPDE-treated Hela and bronchial epithelial cells at the same guanine positions in specific p53 codons that are the major mutational hotspots in human lung cancer (Denissenko et al., 1996) . It was argued that targeted adduct formation was more likely to shape the p53 mutational spectrum in lung cancer than phenotype selection. The foundation of this argument was said to be faulty, however, because it apparently lacked the critical control of non-smoking lung cancer cases and the data did not rule out that p53 mutations were anything other than predominantly endogenous in origin (Krawczak and Cooper, 1998) . This was followed by an analysis using new tests that focused on complementary base substitutions using an updated data base of p53 mutations of the International Agency for Research and Cancer (Rodin and Rodin, 2000) . The analysis indicated that the hotspots of mutations in the p53 gene of lung cancer arise from strand-specific repair of primary lesions and site-specific selection of the resultant mutations. The authors concluded that physiological stresses (not necessarily genotoxic) aggravated by smoking are the leading risk factor in the p53-associated etiology of lung cancer, although an interplay with mutagenesis was not excluded.
The critique of the direct mutation model of tobacco carcinogenesis was countered in a further update of the p53 mutation database as well as recent data from the primary literature on non-smokers (Hainaut and Pfeifer, 2001) . It was concluded 'that the p53 mutation spectra are different between smokers and non-smokers and that this difference is highly statistically significant.' The 'data reinforced the notion that p53 mutations in lung cancer are the result of direct DNA damage from cigarette smoke carcinogens rather than selection of pre-existing endogenous mutations.' Further data were consistent with this hypothesis, and showed that nontumorous lung tissues from smokers carry a high p53 mutational load at codons consistent with the hypothesis (Hussain et al., 2001) .
In a second rebuttal of this view, support was presented for factors in addition to the direct mutagenic action of PAH-like carcinogens in lung cancer (Rodin and Rodin, 2002) . The authors of this report found a pronounced strand bias in p53 G?T transversions but not in the C?A strand mirror image counterpart. Along with other data, this strand bias suggested that smoking inhibits repair of G?T primary lesions on the non-transcribed strand of DNA. They also report an additional excess of G?T transversions in cell cultures compared to the parental primary tumors, which could not have come about by smoking exposure. They ascribed the new G?T transversions to other mutagens such as reactive oxygen and nitrogen species.
None of the papers in this interchange mentioned any historical evidence from experimental studies on tobacco carcinogenesis that contrasted the grossly subeffective concentrations in cigarette smoke of BP and other PAHs with the effective concentrations of promoters and co-carcinogens. As already discussed here, these studies indicated that promotion and cocarcinogenesis were necessary for neoplastic expression of PAH-induced lesions from cigarette smoke. They also showed that selection of endogenous mutations was insufficient to explain the results, i.e., there had to be induction of new mutations as well. It should be noted that there are carcinogens in cigarette smoke in addition to the PAHs, such as the relatively specific lung carcinogen, nicotine-derived nitrosamine ketone (NNK) (Hecht, 1999; Hecht and Hoffmann, 1988) . Cigarette smoke contains substantial amounts of NNK, and the total dose experienced by a smoker in a lifetime is close to the lowest total dose that induces lung tumors in rats (Hecht, 1999) . However, NNK has not been tested by local administration in the respiratory tract, and the relation of dose to weight is, of course, much higher in the rat than an equal dose in humans. It was noted (Hecht, 1999 ) that a variety of activated carcinogens, including NNK target methylated CpG sites in the p53 gene just as BPDE does (Chen et al., 1998; Denissenko et al., 1997) 1 . It was surmised that 'the assignment of these mutations to specific carcinogens is at best speculative' (Hecht, 1999) . It seems clear, however, that interplay exists between the specific mutagenic action of cigarette smoke and its ability to induce clonal selection.
Modes of selection
As already noted, PAH-induced mutations arise from covalent adducts of their diol epoxides to either guanine as in the case of B(a)P (Sims et al., 1974) or adenine as in the cases of DMBA and DB(a,l)P (Cheng et al., 1988; Ralston et al., 1995) . The formation of the bulky BPDE adduct at the N2 position of guanine results predominantly (70%) in G?T transversions which is the mutational signature of BPDE (Ruggeri et al., 1993) . The role of smoke-induced mutations in tobacco carcinogenesis is to be considered by others in this Review issue, e.g., Chemical Carcinogenesis by Pfeifer and Hecht and Molecular Epidemiology by Hussain and Harris. The combination of mutagens and clonal selection cannot be resolved without considering the historical experimental work described here which concluded that the concentration of PAHs in cigarette smoke is far too low to account by itself for the carcinogenic activity of the condensate (Wynder and Hoffmann, 1959, 1961) and the activity of promoters and co-carcinogens is high enough to contribute significantly to tumor development (Gellhorn, 1958; Hecht et al., 1981; Roe et al., 1959; Van Duuren and Goldschmidt, 1976; Van Duuren et al., 1966) .
One of the clearest models of selection by promoters comes from the action of TPA on keratinocytes isolated from initiated mouse skin. TPA causes differentiation of most of the keratinocytes, but stimulates the multiplication without differentiation of those initiated by prior in vivo PAH treatment (Yuspa and Morgan, 1981) . There are even some spontaneously initiated cells in normal, untreated skin that are resistant to the differentiating action of TPA and are selected for expansive growth (Yuspa et al., 1982) . With repeated application of the promoter, the initiated cells proliferate and accumulate mutations that convert them to neoplastic behavior (Parkinson, 1985) . Similar events could occur in the lungs of smokers, since the initiation-promotion sequence has been demonstrated in the lungs of newborn mice (Armuth and Berenblum, 1972) .
Tumor microenvironment
One aspect of PAH interaction with DNA that has received very little consideration in carcinogenesis is the large number of stable DNA adducts -around 50 000 -produced per epidermal cell in 24 h with each skin painting of a carcinogenic dose (Melendez-Colon et al., 1999) . It is estimated that anywhere from 0.04 to 0.9% of the stable adducts to E. coli DNA result in G?T mutations, depending on whether DNA repair systems are induced, and the strain of bacterium used as a target (Mackay et al., 1992) . Assuming these figures have some validity for animal cells, 20 or more mutations would occur in each epidermal cell of BPtreated mouse skin. Many of the epidermal cells are killed at higher doses of PAH (Cramer and Stowell, 1942b) or exhibit damage in the form of nuclear and cytoplasmic swelling (see Figure 1b) . The proportion of surviving cells increases with the repeated applications of PAH that are required for complete carcinogenesis (Cramer and Stowell, 1942b) indicating from the estimates of mutation frequencies per stable DNA adduct that mutations occur not only in the cells destined to initiate tumors but also in the surrounding microenvironment. The increased survival of cells with repeated application of PAH is consistent with selection of resistant cells, many likely to be carrying PAH-induced mutations and altering the microenvironment for the potential tumor cells in their midst. One indication of a region-wide change in the area painted with PAH is a long term increase in sensitivity of growth stimulation by promoter (Frankfurt and Raitcheva, 1973) . Five weeks after initiation by a single application of DMBA to the skin of mice, a single painting with a promoter resulted in a much faster onset of DNA synthesis and a larger number of responding cells than in uninitiated skin. The result was interpreted as the appearance of diffuse incipient neoplasia involving all basal cells of the epidermis. The number of cells per 1 mm length of epidermis remained 2 -3 times higher for days after promoter treatment of initiated skin than of uninitiated skin (Frankfurt and Raitcheva, 1972) . This is clear evidence of hyperplasia, a common early event in carcinogenesis and a further 1 It is noteworthy that the skin of p53-null mice initiated with DMBA and promoted with TPA developed only one-fifth as many papillomas as p53 heterozygous and wild type mice (Kemp et al., 1993) . However, the papillomas of the p53 null mice progressed to carcinomas much faster than those of the other two strains, while the final percentage of carcinomas was much higher in both p53-null and heterozygous mice than the wild type mice. There is also evidence that clonal expansion of p53 mutant cells is associated with progression of human brain tumors (Sidransky et al., 1992) . sign of a long term pervasive increase in sensitivity to mitogenic effectors.
The role of the microenvironment in neoplastic development was first noted over 40 years ago during experiments on the transformation of chicken embryo cells infected with RSV (Rubin, 1960) . When a high proportion of the cells was infected, they became morphologically transformed in a medium either of high or moderate growth stimulatory activity. When only a small proportion of the cells was infected, transformation occurred only in the high stimulatory medium even though the same number of cells actively produced RSV in both media. The implication was that the combination of a contact-inhibited cellular environment of normal cells and a less stimulatory medium inhibited the transformation and multiplication of the fraction of infected cells. High growth stimulation by the medium relieved the contact inhibition imposed on the infected cells by the confluent normal cell microenvironment surrounding them, which permitted the transformation and focus formation by the former. When the microenvironment consisted of RSV-infected cells, which were less subject to contact inhibition by virtue of their incipient transformation, all of them transformed even in medium of relatively low stimulatory activity. The implication of these results was that both the humoral and cellular microenvironments influenced the expression of the neoplastic phenotype.
In the following years, moderating effects by microenvironments of normal cells on transformation of cells infected with different tumor viruses were demonstrated in primary cultures from various species, with evidence that direct contact between the cell types was required to produce the effect (Stoker, 1964; Weiss, 1970) . A similar inhibition was observed on spontaneously transformed mouse cells of the established NIH3T3 line by non-transformed cells of the same line, but only when the latter were themselves relatively refractory to spontaneous transformation (Rubin, 1994a) . It was found that serial rounds of selection for growth at high density, which resulted in progressive increases in saturation density before foci appeared, increased the permissiveness of the culture for expression of the transformed state by a few cells that had progressed further than the others (Chow and Rubin, 1999 ; and the present Figure 2) . In growing to a higher saturation density, the non-transformed cell microenvironment allowed unrestricted growth of the more advanced few among them that was required to produce large, fully transformed foci. In a microenvironment of non-selected cells with a low saturation density, the large foci that would have been formed by selectively transformed cells in the permissive microenvironment were markedly reduced in size ( Figure 6 in Chow and Rubin, 1999 ; and the present Figure 2) . Cells in an earlier stage of transformation that produced small foci in a permissive background were unable to produce detectable foci in the more stringent, non-selected background (Figure 2; and Rubin, 2002 Submitted) . This indicates that the susceptibility of cells to control by their microenvironment is greatest in the early stages of transformation. The non-selected microenvironment could be made permissive by increasing the serum concentration, thereby increasing the saturation density.
Growth of non-transformed cells to high saturation density is the in vitro equivalent of hyperplasia in vivo. Hyperplasia is an early response to carcinogenic PAH Figure 2 Selection of cells to make a high saturation density microenvironment that is permissive for maximum expression of focus formation by transformed cells. The NIH3T3 line of mouse embryo cells was used in procedures described in Rubin, 1994b . The 18 assay in 60 MM dishes of 10 5 cells in 2% calf serum (CS) for 2 weeks is of cells that had been maintained in non-selective, frequent low density passages, and that multiplied to a low saturation density without passage, with no transformed foci. The 28 and 38 assays were derived from a culture of the same origin but had been kept in 10% CS for 3 weeks (not shown) to maximize selection for multiplication to a high saturation density (20610 5 ). The cells were then used for serial 28 and 38 assays of 10 5 cells each in 2% CS for 2 weeks. In addition, the 38 assay was done with 10 4 cells from the 28 assay which were mixed with 10 5 non-selected cells to create a smooth, confluent background for focus formation. The results show that the 28 assay of cells from the 3 week selection in 10% CS grew to more than double the saturation density in 2% CS of the unselected cells of the 18 assay, with a few beginning foci. The 38 assay of 10 5 cells exhibited about 40 large, dense transformed foci of a tumorigenic type, and a large number of smaller and/or lighter foci. The saturation density, which included the background of non-transformed selected cells, was 16 times higher than that of the original unselected cells. When 10 4 cells from the selective 28 assay were mixed with 10 5 unselected cells, there was the expected 10-fold reduction in the number of large, dense foci, but they were markedly reduced in size, and the numerous smaller or lighter foci seen in the 10 5 cell assay were completely absent. The results show the cells selected for growth at high density form a permissive background for the multilayered focal growth of transformed cells. The use of unselected cells with their low saturation density as background markedly reduced the size of foci by the most transformed cells and completely suppressed focus formation by less transformed cells. ND, saturation density not determined painting of mouse skin and an essential component of promotion (Kaina, 1989; Parkinson, 1985; Setala et al., 1959; and present Figure 1) . It is also a pervasive feature of the bronchial epithelium of smokers, and persists to a considerable degree more than 5 years after smoking has ceased (Auerbach et al., 1962 ; and the present Table 6 and Figure 3) 1 . Reasoning from the cell culture model, the persistent bronchial hyperplasia might be expected to act as permissive microenvironment for progression to, and expression of, the neoplastic phenotype by the most transformable cells in the hyperplastic population. This view gains plausibility from experiments on the proliferation of neoplastic tracheal epithelial cells of rats in the presence of normal or preneoplastic tracheal epithelial cells (Terzaghi-Howe, 1987) . The preneoplastic cells had been exposed to x-rays and, when cultured alone on denuded tracheal grafts, yielded a non-invasive, organized metaplastic or undifferentiated epithelium. The mixtures were seeded on denuded tracheas that were transplanted subcutaneously into syngeneic rats. The normal tracheal cells powerfully inhibited the growth of the neoplastic cells, but the preneoplastic cells allowed unhindered growth of the neoplastic cells. The inhibition by normal cells apparently required close contact with the neoplastic cells, since there was no inhibition when the neoplastic cells occupied a contiguous area of the trachea.
A related set of observations was made with a nontumorigenic line of human prostatic epithelial cells immortalized by transfection with SV40-large T antigen (Olumi et al., 1999) . These cells were mixed with fibroblasts isolated from human prostate carcinoma or from normal human prostate and inoculated into nude mice. The fibroblasts from the carcinoma stimulated the growth of the immortalized epithelial cells and directed their progression to tumor production. No tumor formation occurred in mixtures containing the immortalized epithelial cells and fibroblasts from normal prostate, nor when carcinomaassociated fibroblasts were mixed with normal prostate epithelium. The epithelial cells derived from tumors induced by the tumorigenic mixture were then fully malignant by themselves in subsequent grafts showing that true progression had occurred (Hayward et al., 2001) .
A recent report indicates an important role of an altered cellular microenvironment for tumor production in UV irradiated epidermis . Sun-exposed human skin contains thousands of p53 mutant keratinocytes. These keratinocytes are histologically normal yet contain the same kinds of p53 mutations commonly found in more than 90% of squamous cell carcinomas. Similar clones are present in mouse skin irradiated with UVB, and correlate with tumor risk. The clones are 'imprisoned' within 1 It is of interest that Auerbach's histopathological studies of smokers' lungs at autopsy played a powerful role in widespread acceptance of smoking as the major cause of lung cancer and were prominently cited in the 1964 Surgeon General's report about the dangers of smoking (Burkhart, 1997) . This resulted in the requirement that cigarette packages carry a warning that cigarettes could be harmful to health, and it was estimated that in the next 25 years 750 000 lives had been saved by people's decisions not to smoke (ibid.). The decrease in cigarette smoking in men that began in the 1960's was followed, after 1980, in a decreasing mortality for lung cancer. A further finding of Auerbach and colleagues that influenced public opinion about the dangers of smoking came from an experiment in which dogs were taught to smoke cigarettes through a tracheostoma. Eight of 12 dogs that were killed after 2.4 years of smoking seven unfiltered cigarettes per day developed invasive bronchiolo-alveolar tumors while none of the eight non-smoking controls developed invasive tumors (Auerbach et al., 1970) .
individual epidermal proliferating units, but clonal expansion is driven by chronic exposure to UVB. The expansion allows the p53 clones to colonize adjacent epidermal proliferative units without incurring additional mutations. It was proposed that the chronic irradiation induces apoptosis in non-mutant cells of the restricting epidermal proliferating unit, which allows selective expansion of the apoptosis-resistant p53 mutant cells to colonize adjacent units.
It has long been known that localized irradiation of the lungs of mice greatly increases the number of artificial pulmonary metastases arising from subsequent intravenous injection of tumor cells (Brown, 1973; Withers and Milas, 1973) . A similar effect is obtained in the lung by pre-injection intraperitoneally of certain cytotoxic drugs (Carmel and Brown, 1977; Milas and Peters, 1984) . PAH treatment of mouse skin causes widespread damage to epidermal cells (Cramer and Stowell, 1942b) , and it is likely that the PAHs and other cytoxic chemicals in cigarette smoke produce a similar effect on the bronchiolo-alveolar epithelium as indicated by cells with atypical nuclei throughout the bronchial epithelium (Table 6 ). Such damage would be expected to facilitate the clonal expansion of any initiated cells among the survivors, including those in the more resistant hyperplastic response. In that sense, cigarette smoke would be acting as both an initiator and promoter much as sunlight is thought to act in epidermal carcinogenesis . It should be encouraging to exsmokers that there was a large drop in the frequency of bronchial cells with atypical nuclei after cessation of cigarette smoking (Table 6 ).
Mutation and selection in neoplastic transformation of cells in vitro
The dynamics of selection in driving neoplastic transformation are most conveniently studied in cell culture. Freshly explanted mouse embryo fibroblasts repeatedly passaged at high density gradually develop a capacity to multiply to higher and higher maximum or saturation densities (Todaro and Green, 1963) and eventually to produce sarcomas upon injection into mice (Aaronson and Todaro, 1968) . Diploid rat liver epithelial cells maintained under contact inhibition at confluence for 3 weeks of every month before passage (selective conditions) gain the capacity to produce hepatocarcinomas in young syngeneic rats in 1/6th the number of cell divisions that are required to do so under non-selective conditions (Lee et al., 1989) . The rat liver cells with no other treatment than long term maintenance under the selective condition of high population density undergo 'spontaneous' transformation much more readily than the same cells treated with a powerful mutagenic carcinogen but frequently passaged at low density to maintain non-selective conditions. These results indicate that selection of endogenous mutations, some possibly induced by crowded conditions at confluence, is a stronger driving force in transformation than the induction of mutations by a carcinogen in cells maintained under nonselective conditions (Rubin, 2001a,b) .
The originally established NIH3T3 line of mouse fibroblasts readily undergoes spontaneous transformation when maintained at confluence for a minimum of 10 days and then subcultured and regrown to confluence to produce foci of transformed cells (Rubin and Xu, 1989) . If the cells are frequently passaged at low density, they tend to lose the competence to undergo transformation (Rubin, 1992) . In agreement with the findings with the rat liver cells, clonal analysis showed that selection is the major driving force in spontaneous transformation (Chow and Rubin, 2000) . Much of the selection occurs in a progressive manner before the cells produce recognizable foci (Rubin, 1994b (Rubin, , 2001a .
The possibility could not be ruled out, however, that the selective conditions of contact inhibition at high population density temporarily destabilized the cells and increased the frequency of genetic change. The genetic change would then add to pre-existing mutations available for selection. The picture would resemble that of adaptive mutation in bacteria that occurred under nutritionally selective conditions (Cairns and Foster, 1991; Cairns et al., 1988) . In one form there is a transient condition of hypermutability during stress to the bacteria which allows permanent mutations, some of which permit survival (Rosenberg et al., 1998) . In a second form there is adaptive amplification of a leaky mutation that permits multiplication under selected conditions but is ultimately reversible in growth under non-selective conditions (Andersson et al., 1998; Hastings et al., 2000) .
There is a delay of several days in the appearance of the selectable mutations or amplifications and the newly altered cells form colonies at a faster rate than the originally emergent colonies (Hastings et al., 2000) . This has a parallel in the spontaneous transformation (Rubin and Xu, 1989) . If some primary cultures are passaged at successive intervals after they are first seeded, a very small fraction of the cells show up as focus formers in the secondary cultures passaged at 7 days, with a 10-fold increase in transformed cells showing up in the secondary cultures from the 9 day passage. In that 2 day interval there is actually a slight decrease in the total number of cells in the primary cultures, due to death of some cells under contact inhibition, so it is only when the cultures have become quiescent and some are damaged that transformation begins (Yao and Rubin, 1994) . Evidence of populationwide genetic damage is seen in a heritable reduction in growth rate of the entire population of cells on passage at low density (Rubin et al., 1995) .
The results suggest an increase in genetic change under inhibited growth at confluence with continuing growth of some altered clones under the selective conditions. The results in culture support those observed in mouse skin in the initiation-promotion sequence. Large numbers of papillomas are produced in the full sequence of PAH initiation with a single application of PAHs and promotion with TPA, but very few are produced by TPA alone. This indicates there is selection of some endogenous mutations or chromosome rearrangements to account for the few tumors produced by TPA alone, but many more such tumors appear in the TPA treatment of initiated skin which indicates that the initiating carcinogen had induced many more such genetic lesions.
Precancerous pulmonary lesions among smokers
PAHs are complete carcinogens in that they act in repeated applications as both initiators and promoters, although the promotion by the PAHs might more appropriately be called co-carcinogenesis because the action accompanies rather than follows initiation. It is difficult to separate the anatomic effects of initiation and promotion of the PAHs because of their dual role, but a single application of even large doses produces only a light hyperplasia at 6 days, which has largely subsided by 30 days (Setala et al., 1959) , suggesting that hyperplasia is not necessary for initiation. This suggestion is reinforced by the finding that a pure initiator in skin such as urethane causes no visible histopathology (Salaman and Roe, 1953) . By contrast, repeated applications of a promoter in uninitiated and initiated skin produces extensive hyperplasia (Setala et al., 1959) . Different strains of mice with variable sensitivity to tumor promotion by TPA exhibit a good correlation of long term tumor production with sustained hyperplasia after 4 weeks of repeated TPA treatment (Sissken et al., 1982) . There is also a correlation between thickness of epidermis and tumor production in the tumor-producing range of TPA concentrations (Raick et al., 1972) . The combined evidence indicates a strong relation between promotion and hyperplasia.
All of the above findings were made in mouse skin and the question arises of their relevance to the effect of smoking in human lung. A series of studies were done comparing the extent of hyperplasia and other bronchial lesions upon autopsy of men with varying histories of smoking who had died of causes other than lung cancer, as well as some biopsies and autopsies from smokers who had lung cancer (Auerbach et al., 1956 (Auerbach et al., , 1961 (Auerbach et al., , 1962 . Data from the last of these studies is abstracted in Table 6 .
The incidence of sections with hyperplasia is indicated in the column labeled '3+ rows of cells'. The incidence among matched triads was 92.7% in current regular smokers, 57.3% in ex-smokers and 12.1% in non-smokers. The most pronounced difference among the three groups of subjects was in the occurrence of cells with atypical nuclei ranging from 93.2% in current smokers, 6.0% in ex-smokers and 1.2% in non-smokers. The high incidence of hyperplasia in smokers can be taken as evidence of a promotional effect of smoking. There was a significant decrease in hyperplasia among ex-smokers and a much larger decrease among non-smokers. There was an even larger decrease in cells with atypical nuclei with cessation of smoking. Not only did the studies of Auerbach et al. (1961 Auerbach et al. ( , 1962 provide strong histological support to the already overwhelming epidemiological evidence that cigarette smoking causes bronchogenic carcinoma in man but they are also consistent with a strong promotional effect of cigarette smoke.
Conclusions
The great bulk of experimental studies on lung carcinogenesis by cigarette smoking has been directed toward the PAHs in the so-called tar fraction or condensate and most of them have used a standardized, repeated painting of mouse skin for tumor production. Obviously, it would have been preferable to use inhalation to produce lung tumors, but that method produced either negative or unreproducible results. Even the skin tests of cigarette smoke condensate were negative in the hands of some early experimenters, indicating the weakness of the carcinogenic constituents. The first consistent, tumorproducing results with painting of condensate on mouse skin were obtained by Wynder and associates in a systematic series of papers in the 1950s. A major conclusion of those studies was that the concentration of the major carcinogenic PAH found in the condensate was BP and that its concentration there was only about 1/50th of that necessary to produce skin tumors when applied alone in the pure state (Wynder et al., 1957b , Wynder and Hoffmann, 1959 , 1961 Wynder and Wright, 1957) . These studies led to the conclusion that 'tobacco smoke condensate is primarily a tumor-promoting agent with weak carcinogenic activity ' (Van Duuren et al., 1971) .
The initiation-promotion procedure does not approximate the long term exposure of cigarette smokers, which exposes the smoker repeatedly to all the constituents at the same time. However cocarcinogenesis, which came to be defined as repeated, simultaneous application of a carcinogen and agents that enhance its activity, more closely simulates the conditions of exposure of the smoker and that procedure demonstrates a number of co-carcinogens in cigarette smoke (Van Duuren and Goldschmidt, 1976) . The co-carcinogenic constituents fall into at least four chemical classes and include some normal body constituents such as stearic acid. The cocarcinogen in the highest concentration in cigarette smoke is catechol, which is a phenol with two adjacent hydroxyl groups (Van Duuren, 1980) . The amount of catechol extracted from five or ten cigarettes is sufficient to act as a co-carcinogen in repeated application to mouse skin.
In considering the two-stage initiation-promotion scheme for tobacco carcinogenesis, it is of interest to note that a carcinogenic application of BP to mouse skin for 24 h is estimated to make about 50 000 stable adducts of BPDE to guanine residues in DNA of a single cell (Melendez-Colon et al., 1999) . Other mutagens in cigarette smoke are likely to raise the stable adduct burden even higher. Hence, there is fertile ground for a promoter or co-carcinogen to eventually provide for expression of the tumorigenic potential of some of the altered cells without the necessity for further mutations. Presumably only a small minority of the mutations would be in tumor suppressor genes or oncogenes, but among the millions of exposed cells there would be some with initiating mutations. An instructive molecular model was obtained by introducing into mouse epidermal cells the activated Harvey sarcoma virus gene, which produced no tumors in skin by itself (Brown et al., 1986) . Subsequent treatment with TPA induced benign tumors, some of which progressed to invasive carcinomas. Initiation was irreversible for at least 4 months. The results showed that activated ras genes can replace chemical carcinogens in the initiation of mouse skin carcinogenesis. In the case of human lung carcinogenesis, both ras and p53 gene mutations are apparently much more common in tumors from smokers than non-smokers (Denissenko et al., 1996; Hainaut and Pfeifer, 2001) .
Since even TPA, the most powerful promoter, is non-mutagenic in hamster cells (Lankas et al., 1977) and does not require metabolic activation for its promoting action (Berry et al., 1978) , it is unlikely that promotion requires adduct formation with DNA. Detailed studies of promotion by TPA indicate there is a relatively stable convertogenic stage (Boutwell, 1964; Fu¨rstenberger et al., 1983) which induces chromosome aberrations (Dzarlieva- Petrusevska and Fusenig, 1985; Petrusevska et al., 1988) , followed by a proliferogenic stage which selects cells for tumor formation that have a fertile combination of endogenous or carcinogeninduced mutations and chromosomal rearrangements (Kaina, 1989) . Weaker promoters such as mezerein (Slaga et al., 1980) or RPA (Fu¨rstenberger et al., 1981) have little convertogenic power but are effective proliferogenic agents. The promoters in cigarette smoke are not as strong as TPA. Although it is unknown how co-carcinogens produce their effect, it is certainly not by direct action on DNA. The mode of action may resemble the proliferogenic, selective stage of promotion. Given the wide variety of chemical classes that the co-carcinogens occupy with some being normal body constituents, it is not unlikely that they act epigenetically to favor the expansion of rogue clones. Changes in both the cellular and humoral microenvironments of the potential cancer cell have to be considered among the conditions that determine the expression of the neoplastic phenotype.
Much effort has been expended in elucidating the biochemical mechanism of promotion but no conclusive results have been obtained (Yuspa and Poirier, 1988) . A complex variety of biochemical reactions are evoked by the classical promoter TPA and there does not seem to be any simple linear series of such reactions that can be related to the hyperplastic or selective responses that are typical of promotion. Nor is it known how many of the biochemical responses to TPA are shared with other promotional treatments such as turpentine, prolonged wound healing, mezerein and RPA. The complexity of response is like that found in stimulation of cell proliferation by growth factors in which almost every biochemical pathway in the cell is affected (Rubin, 1975) . Since that level of complexity makes it virtually impossible to trace causal chains of these processes beyond a terminal point (Elsasser, 1998) , I have taken a purely operational approach in assessing their role in tobacco carcinogenesis. The full range of results favors the active participation of promoters and co-carcinogens as selective agents in addition to mutagens in producing lung cancer by cigarette smoking. Since it has been shown in mice that a 50 -70% reduction in caloric intake in the diet is an effective method of treatment in the promotional stage of tumors in rodents, including pulmonary adenomas (Tannenbaum, 1959) and a low intake of animal fat is associated with reducing the effects of tumor promoters in human tumors (Rose et al., 1986) , it would be of interest to examine the effectiveness of such nutritional modification in managing human lung cancer.
Abbreviations BA, benzanthracene; BP, benzo(a)pyrene; B(e)P, benzo(e)pyrene; BPDE, 7,8-dihydrodiol-9,10-epoxide; BPDE-1, syn or cis isomer of BPDE, also BPDE-II; BPDE-2, anti or trans isomer of BPDE, also BPDE-I; CS, calf serum; DB(a,c)A, dibenz(a,c)anthracene; DB(a,h)A, dibenzo(a,h)anthracene; DB(a,l)P, diben-zo(a,l)pyrene; DMBA, 7,12-dimethylbenzanthracene; MCA, 3-methylcholanthrene; NNK nicotine-derived nitrosamine ketone; PAHs, polycyclic aromatic hydrocarbons; RPA, phorbol-12-retinoate-13-acetate; RSV, Rous sarcoma virus; TPA, 12-0-tetradecanoylphorbol-13-acetate; TPNH, reduced form of triphosphopyridine nucleotide
